Not applicableStudy completedNCT06282328What this trial is testingHIV HOspital TEsting: Bringing the Hidden to Light in the Hospital SettingWho this might be right forHivHIV InfectionsAIDS Castagna Antonella 300
Not applicableUnknownNCT01681706What this trial is testingHIV Indicator Diseases Across Europe StudyWho this might be right forHIV Jesper Grarup 14,000
Not applicableUnknownNCT05666882What this trial is testingEffect on the HIV Diagnosis Rates of Integration of AIDS Indicator Conditions Into the Hospital Information SystemsWho this might be right forHIV Infections Ankara University 10,000
Not applicableUnknownNCT02889094What this trial is testingFrench HIV-HBV CohortWho this might be right forHepatitis BHIVLiver Cirrhosis+1 more Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 152
Not applicableStudy completedNCT03236532What this trial is testingEffect of Supplementation With Glutamine and Exercise in Women With HIV/AIDSWho this might be right forGlutamine; Metabolic DisorderPhysical Activity State University of Maringá 14
Not applicableStudy completedNCT03228966What this trial is testingPed HIV - Echo Study: KenyaWho this might be right forHIV/AIDSCardiomyopathies Duke University 643
Not applicableUnknownNCT05225493What this trial is testingHIV Indicator Diseases in Hospital and Primary CareWho this might be right forHIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more Erasmus Medical Center 1,500
Not applicableUnknownNCT01196468What this trial is testingHIV Indicator Diseases Survey Across Europe - UK ArmWho this might be right forHIVAIDSIndicator Diseases/Indicator Conditions Chelsea and Westminster NHS Foundation Trust 2,000
Not applicableLooking for participantsNCT02956031What this trial is testingScreening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.Who this might be right forCervical CancerHigh Grade SilCIN2 University of Pretoria 1,500
Testing effectiveness (Phase 2)Study completedNCT00002106What this trial is testingA Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3Who this might be right forHIV Infections Glaxo Wellcome 104